The biotech ETF is up more than 20% this year, earning a spot on IBD’s ETF Leaders screen. It’s done that with a portfolio that’s concentrated on just 30 holdings.
— Read on www.investors.com/etfs-and-funds/etf-leaders/biotech-etf-first-trust-nyse-biotechnology-index-fund/